Sun Pharmaceuticals Industries reports consolidated net loss of Rs 2277.25 crore in the March 2022 quarter

Sales rise 10.90% to Rs 9386.08 crore

Net loss of Sun Pharmaceuticals Industries reported to Rs 2277.25 crore in the quarter ended March 2022 as against net profit of Rs 894.15 crore during the previous quarter ended March 2021. Sales rose 10.90% to Rs 9386.08 crore in the quarter ended March 2022 as against Rs 8463.74 crore during the previous quarter ended March 2021.

For the full year,net profit rose 12.70% to Rs 3272.73 crore in the year ended March 2022 as against Rs 2903.82 crore during the previous year ended March 2021. Sales rose 15.63% to Rs 38426.42 crore in the year ended March 2022 as against Rs 33233.08 crore during the previous year ended March 2021.

ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales9386.088463.74 11 38426.4233233.08 16 OPM %24.9324.20 -27.0625.55 - PBDT2416.622129.34 13 11191.889185.46 22 PBT1860.151575.85 18 9048.147105.51 27 NP-2277.25894.15 PL 3272.732903.82 13

Powered by Capital Market - Live News